Romel Membrano
Non-Executive Chairman
life sciencess
ChemTreat
Bahamas
Biography
nd the development of AstraZeneca compound profilers for research programs, clinical candidates and the corporate compound collection. Previously, at Zeneca Pharmaceuticals, he spearheaded modern medicinal chemistry together with the development of proprietary chemical technologies and chemical libraries that were industrialized across a number of therapeutic areas. Dr. Kocis is one of the pioneers of combinatorial chemistry and of the concept of chemical libraries, especially libraries exploiting medicinally relevant chemical space. He was instrumental in building Selectide’s combinatorial ch
Research Interest
nd the development of AstraZeneca compound profilers for research programs, clinical candidates and the corporate compound collection. Previously, at Zeneca Pharmaceuticals, he spearheaded modern medicinal chemistry together with the development of proprietary chemical technologies and chemical libraries that were industrialized across a number of therapeutic areas. Dr. Kocis is one of the pioneers of combinatorial chemistry and of the concept of chemical libraries, especially libraries exploiting medicinally relevant chemical space. He was instrumental in building Selectide’s combinatorial ch
